1. Home
  2. WHG vs SGMO Comparison

WHG vs SGMO Comparison

Compare WHG & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westwood Holdings Group Inc

WHG

Westwood Holdings Group Inc

HOLD

Current Price

$16.84

Market Cap

173.6M

Sector

Finance

ML Signal

HOLD

Logo Sangamo Therapeutics Inc.

SGMO

Sangamo Therapeutics Inc.

HOLD

Current Price

$0.19

Market Cap

141.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WHG
SGMO
Founded
1983
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
173.6M
141.2M
IPO Year
2002
2000

Fundamental Metrics

Financial Performance
Metric
WHG
SGMO
Price
$16.84
$0.19
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.00
AVG Volume (30 Days)
6.4K
8.0M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
3.61%
N/A
EPS Growth
203.85
10.20
EPS
0.79
N/A
Revenue
$97,762,000.00
$36,567,000.00
Revenue This Year
N/A
$107.15
Revenue Next Year
N/A
$76.44
P/E Ratio
$21.47
N/A
Revenue Growth
3.21
88.60
52 Week Low
$14.51
$0.14
52 Week High
$18.99
$0.79

Technical Indicators

Market Signals
Indicator
WHG
SGMO
Relative Strength Index (RSI) 60.37 31.59
Support Level $17.28 N/A
Resistance Level $18.68 $0.55
Average True Range (ATR) 0.66 0.03
MACD 0.07 -0.00
Stochastic Oscillator 100.00 36.11

Price Performance

Historical Comparison
WHG
SGMO

About WHG Westwood Holdings Group Inc

Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States.

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: